| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000260805.99076.22 |
| P698 | PubMed publication ID | 17303761 |
| P50 | author | Antonio Baldini | Q89356799 |
| Katarzyna A Cieslik | Q98772829 | ||
| P2093 | author name string | Matteo Vatta | |
| Luca Brunelli | |||
| Joseph L Alcorn | |||
| P2860 | cites work | Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta | Q38322740 |
| P433 | issue | 5 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | e59-71 | |
| P577 | publication date | 2007-02-15 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta | |
| P478 | volume | 100 |
| Q36402571 | 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening. |
| Q36126310 | 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease |
| Q39435906 | 14-3-3epsilon controls multiple developmental processes in the mouse heart |
| Q36435187 | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle |
| Q34317168 | Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells |
| Q33419214 | Curcumin suppresses PPARdelta expression and related genes in HT-29 cells |
| Q39620800 | Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. |
| Q47141643 | Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q37711312 | Effects of ethanol on the proteasome interacting proteins |
| Q37082602 | Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice |
| Q34086987 | Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation |
| Q38125279 | Molecular biology of atherosclerosis |
| Q37037802 | PPAR-delta in Vascular Pathophysiology |
| Q24642728 | PPARs and the cardiovascular system |
| Q41904877 | PPARδ activity in cardiovascular diseases: A potential pharmacological target |
| Q36326958 | PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice |
| Q37547644 | PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance |
| Q37045216 | PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation |
| Q53406338 | Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks. |
| Q34179017 | Peroxisome proliferator-activated receptors for hypertension |
| Q35636191 | Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease |
| Q38016600 | Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience |
| Q34092981 | The current state of chromatin immunoprecipitation |
| Q36287741 | Vascular effects of prostacyclin: does activation of PPARδ play a role? |
| Q37259132 | α-Synuclein overexpression represses 14-3-3θ transcription |
Search more.